Infinity Pharmaceuticals (INFI) News Today → The only AI company to buy (From Porter & Company) (Ad) Free INFI Stock Alerts Notice: This company has been marked as potentially delisted and may not be actively trading. Add Compare Share Share HeadlinesStock Analysis All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative May 7, 2024 | finance.yahoo.comSeaport Therapeutics Adds Industry Veteran to Board of Directors and Makes Key Executive AppointmentsMay 2, 2024 | finance.yahoo.comQ1 2024 Glaukos Corp Earnings CallMarch 16, 2024 | nytimes.comPi Day: How One Irrational Number Made Us ModernMarch 14, 2024 | msn.comBiotech bankruptcies hit a record despite sector’s recoveryMarch 13, 2024 | benzinga.comDavid Schnell's Net WorthMarch 11, 2024 | msn.comMemphis Police issue alert after mother and two children abductedJanuary 31, 2024 | finance.yahoo.comStryker Expands Prophecy® Surgical Planning System to Include the New Footprint™, Offering Surgeons a Comprehensive View of the Foot and AnkleDecember 22, 2023 | seekingalpha.comAGNPF Algernon Pharmaceuticals Inc.December 12, 2023 | morningstar.comInfinity Pharmaceuticals Inc INFIQDecember 1, 2023 | seekingalpha.comINFIQ Infinity Pharmaceuticals, Inc.October 16, 2023 | businesswire.comINFI DEADLINE TODAY: ROSEN, SKILLED INVESTOR COUNSEL, Encourages Infinity Pharmaceuticals, Inc. Investors to Secure Counsel Before Important October 16 Deadline in Securities ...October 16, 2023 | barrons.comFINAL DEADLINE TODAY: The Schall Law Firm Encourages Investors in Infinity Pharmaceuticals, Inc. with Losses of $500,000 to Contact the FirmOctober 15, 2023 | stockhouse.comInfinity Ongoing Deadline AlertOctober 14, 2023 | bloomberg.comDeadline Alert: Bronstein, Gewirtz & Grossman LLC Announces that Infinity Pharmaceuticals, Inc. (INFI) Investors Have OpportuniOctober 10, 2023 | finance.yahoo.comInfinity Pharmaceuticals, Inc. (INFIQ)October 9, 2023 | barrons.comBronstein, Gewirtz & Grossman LLC Notifies Infinity Pharmaceuticals, Inc. (INFI) Investors of Class Action and to Actively Participate!October 2, 2023 | bizjournals.comGutted Cambridge biotech declares bankruptcy after failed merger, layoffsOctober 1, 2023 | markets.businessinsider.comInfinity Investor Shareholder AlertSeptember 29, 2023 | msn.comInfinity Pharmaceuticals reportedly files for Chapter 11September 22, 2023 | finanznachrichten.deFaron Pharmaceuticals Oy: Faron Pharmaceuticals Announces Board ChangesSeptember 18, 2023 | stockhouse.comINVESTOR ACTION REMINDER: The Schall Law Firm Encourages Investors in Infinity Pharmaceuticals, Inc. with Losses of $100,000 to Contact the FirmSeptember 16, 2023 | prnewswire.comINFINITY DEADLINE ALERT: Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $100,000 In Infinity To Contact Him Directly To Discuss Their OptionsSeptember 16, 2023 | markets.businessinsider.comROSEN, A TOP RANKED LAW FIRM, Encourages Infinity Pharmaceuticals, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - INFISeptember 15, 2023 | stockhouse.comINVESTOR ACTION ALERT: The Schall Law Firm Encourages Investors in Infinity Pharmaceuticals, Inc. with Losses of $100,000 to Contact the FirmSeptember 14, 2023 | stockhouse.comSHAREHOLDER ACTION NOTICE: The Schall Law Firm Encourages Investors in Infinity Pharmaceuticals, Inc. with Losses of $100,000 to Contact the FirmSeptember 13, 2023 | gurufocus.comDirector Adelene Perkins Sells 410,196 Shares of Infinity Pharmaceuticals Inc (INFI)September 13, 2023 | stockhouse.comSHAREHOLDER ACTION REMINDER: The Schall Law Firm Encourages Investors in Infinity Pharmaceuticals, Inc. with Losses of $100,000 to Contact the FirmSeptember 13, 2023 | seekingalpha.comInfinity Pharmaceuticals receives delisting determination letter from NasdaqSeptember 11, 2023 | stockhouse.comINVESTOR ACTION NOTICE: The Schall Law Firm Encourages Investors in Infinity Pharmaceuticals, Inc. with Losses of $100,000 to Contact the FirmSeptember 6, 2023 | benzinga.comINFI Stockholders Should Contact Robbins LLP for Information About the Class Action Involving Infinity Pharmaceuticals, Inc.September 6, 2023 | stockhouse.comInfinity Shareholder NoticeSeptember 6, 2023 | finanznachrichten.deDEADLINE ACTION ALERT: The Schall Law Firm Encourages Investors in Infinity Pharmaceuticals, Inc. with Losses of $100,000 to Contact the FirmSeptember 5, 2023 | finance.yahoo.comThree execs leave Infinity Pharmaceuticals after failed merger, layoffsSeptember 2, 2023 | stockhouse.comSHAREHOLDER ACTION ALERT: The Schall Law Firm Encourages Investors in Infinity Pharmaceuticals, Inc. with Losses of $100,000 to Contact the FirmAugust 28, 2023 | benzinga.comINFI Stock News: Investors with Significant Losses in Infinity Pharmaceuticals, Inc. Should Contact Robbins LLP About RecoveryAugust 27, 2023 | prnewswire.comROSEN, TOP RANKED GLOBAL COUNSEL, Encourages Infinity Pharmaceuticals, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - INFIAugust 25, 2023 | markets.businessinsider.comInfinity Shareholder Action ReminderAugust 24, 2023 | businesswire.comInfinity Pharmaceuticals, Inc. (INFI) Class Action Alert: Robbins LLP Reminds Investors of the Lead Plaintiff Deadline in the Infinity Pharmaceuticals, Inc. Securities Class ActionAugust 23, 2023 | benzinga.comSHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Infinity Pharmaceuticals, Inc. - INFIAugust 21, 2023 | benzinga.comInfinity Pharmaceuticals, Inc. (INFI) Shareholder Notice: Robbins LLP Reminds Investors of Class Action Filed Against Infinity Pharmaceuticals, Inc.August 20, 2023 | prnewswire.comROSEN, A LEADING LAW FIRM, Encourages Infinity Pharmaceuticals, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - INFIAugust 19, 2023 | businesswire.comINFINITY ALERT: Bragar Eagel & Squire, P.C. Announces that a Class Action Lawsuit Has Been Filed Against Infinity Pharmaceuticals, Inc. and Encourages Investors to Contact the FirmAugust 18, 2023 | benzinga.comThe Law Offices of Frank R. Cruz Announces the Filing of a Securities Class Action on Behalf of Infinity Pharmaceuticals, Inc. (INFI) InvestorsAugust 17, 2023 | technews.tmcnet.comShareholder Alert: Robbins LLP Informs Shareholders of Class Action Filed Against Applied Infinity Pharmaceuticals, Inc. (INFI)August 8, 2023 | au.finance.yahoo.comINFI - Infinity Pharmaceuticals, Inc.August 8, 2023 | markets.businessinsider.comWhy Is Infinity Pharmaceuticals (INFI) Stock Up 84% Today?July 26, 2023 | seekingalpha.comInfinity Pharma cuts jobs, seeking "strategic transaction" for eganelisibJuly 26, 2023 | finance.yahoo.comInfinity Pharmaceuticals Announces Value Preservation and Maximization PlanJuly 24, 2023 | seekingalpha.comInfinity Pharmaceuticals stock plummets on terminating merger agreement with MEI PharmaJuly 24, 2023 | marketwatch.comInfinity Pharmaceuticals Ends Merger Agreement With MEI Pharma Get Infinity Pharmaceuticals News Delivered to You Automatically Sign up to receive the latest news and ratings for INFI and its competitors with MarketBeat's FREE daily newsletter. Email Address Buy this small stock before coming AI Tidal Wave (Ad)The internet generated more wealth than any other innovation in history - creating hundreds of thousands of new millionaires in America alone. Now A.I. could do the same. But if you're buying Microsoft or NVIDIA to profit - you're missing the big picture. Get the name and ticker symbol for free - just click here. INFI Media Mentions By Week INFI Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. INFI News Sentiment▼0.000.77▲Average Medical News Sentiment INFI News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. INFI Articles This Week▼01▲INFI Articles Average Week Get Infinity Pharmaceuticals News Delivered to You Automatically Sign up to receive the latest news and ratings for INFI and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: Histogen News Today Bellerophon Therapeutics News Today Sunshine Biopharma News Today SciSparc News Today Virpax Pharmaceuticals News Today Comera Life Sciences News Today China SXT Pharmaceuticals News Today Aditxt News Today Evofem Biosciences News Today Athersys News Today Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:INFI) was last updated on 6/2/2024 by MarketBeat.com Staff From Our PartnersWrite this ticker symbol down…StocksToTradeTrump’s Gift Could Unleash $51 Billion in New WealthWealthpin ProBiden Nomination CANCELED?The Freeport SocietyBuy this small stock before coming AI Tidal WaveChaikin AnalyticsWarren Buffett, Jeff Bezos, Michael Bloomberg, & 48 Members of Congress Are Buying ONE Sector…InvestorPlaceExposed: 10 CENT Crypto to Explode May 20th?True Market InsidersHe Is Giving Away BitcoinCrypto Swap ProfitsShocking $16T Elon Musk Crypto LeakCrypto 101 Media Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Infinity Pharmaceuticals, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
